Now I have sufficient information from the calibration. Let me write the final consolidated review.

## Summary
ProteinVista introduces a 3D CNN operating on voxelized full-atom protein structures (123M parameters, 5-channel density grids at 1.0Å resolution, adaptive box sizing to control sparsity). It is contrastively pre-trained against ESM-2 embeddings on ~500K AlphaFold-2 structures and evaluated on three binding tasks (TSP, ESP, IC50) plus GO annotation. The paper demonstrates that a full-atom 3D CNN can match or exceed sequence transformers on structure-dependent tasks while using ~1% of the pre-training compute.

## Strengths
- **Controlled comparison isolating the protein encoder**: Section 3.1 specifies that all models receive identical MolFormer embeddings and the same two-layer prediction head (256 hidden units, batch norm, ReLU), with shared hyperparameter search and early-stopping. This design cleanly attributes performance differences to the protein encoder.
- **Quantified compute and data efficiency**: ProteinVista (123M params) uses ~1% of ESM-2_650M's pre-training GPU-hours (192 A100 GPU-hours vs ~21,504 H100 GPU-hours), 5× fewer parameters, and 500× less pre-training data. Section 4.3 and Figure 3 report these comparisons explicitly with measured numbers.
- **Demonstrated sequence-structure complementarity with statistical tests**: The ESM-ProteinVista ensemble outperforms both individual models on TSP (91.5% Acc vs 90.8%/89.3%) and ESP (93.0% vs 91.8%/91.9%). McNemar's tests confirm significance (p < 10^{-13} for TSP, p < 10^{-17} for ESP). The similarity-bin analysis (Figure 2a–c) shows *when* each modality contributes, moving beyond a single aggregate number.
- **Systematic ablation with quantified effect sizes**: Section 4.2 and Figure 2e report the relative R² change for each architectural choice: single-view inference (−6.4%), 1.5Å resolution (−1.1%), Rosetta pretraining (−1.0%), disabling fine-tuning augmentation (−0.1%). This provides concrete evidence for each design decision.
- **Honest reporting of limitations**: Section 3.4 reports that ProteinVista underperforms ESM-2 on GO annotation (F_max 0.57 vs 0.62), and Section 5 discusses the single-rigid-snapshot limitation and the need for dynamic augmentations. This strengthens credibility.

## Weaknesses

### Major
1. **Compute efficiency numbers contain an internal inconsistency that is not adequately explained**: Section 4.3 reports ProteinVista requires 415 GFLOPs per forward pass (vs 140 for ESM-2_150M and 520 for ESM-2_650M) yet processes 1,000 proteins on one A100 GPU in 20 seconds vs 215 seconds for ESM-2_150M and 426 seconds for ESM-2_650M. Even accounting for the backward pass (~2× forward FLOPs), the achieved throughput (≈62 TFLOPs/sec for training-step FLOPs over 20 seconds) exceeds the A100's FP32 peak of 19.5 TFLOPS, though it is achievable under mixed precision (FP16 peak 312 TFLOPS). The paper attributes the gap to "more efficient parallelization" without specifying precision (FP32 vs mixed precision), providing a FLOP-counting methodology, or offering a roofline-style analysis. Since the title and abstract prominently claim "compute-efficient," the reader needs to know the precision used and whether FLOP counts were computed on a consistent basis across models. This is the paper's most significant unresolved issue.

2. **SOTA claims rely on an ensemble, while ProteinVista alone does not surpass published methods**: Table 1 shows ESM-ProteinVista_OP (an optimized-pipeline ensemble of ESM-2 + ProteinVista) surpasses SPOT (92.4% → 93.2% Acc) and ProSmith-ESP (94.2% → 94.4% Acc). However, ProteinVista alone achieves 90.8% on TSP, well below SPOT's 92.4%. Even the simple ESM-ProteinVista ensemble (91.5%) is below SPOT. The paper's text (Section 3.3) is transparent about this being an ensemble result, but the table layout and the overall framing could mislead readers about ProteinVista's independent contribution. A row showing ProteinVista alone under the optimized pipeline is missing, making it impossible to disentangle architecture improvements from ensemble effects.

3. **The contrastive pre-training against ESM-2 creates a framing tension that is partially but not fully addressed**: ProteinVista is pre-trained to align its embeddings with ESM-2 via InfoNCE loss, then fine-tuned and compared *against* ESM-2 on downstream tasks. The Rosetta-only ablation (Section 4.2) partially mitigates this — it shows only a 1.0% relative R² drop — but the paper does not report whether the Rosetta-only variant still outperforms ESM-2 in absolute terms (the implied R² = 0.69 × 0.99 ≈ 0.683 would still beat ESM-2_650M's 0.61). The abstract and title claim "outperforms sequence transformers" without acknowledging that the model was distilled from the very model it is compared against. If the Rosetta-only variant does beat ESM-2, this should be stated explicitly; if not, the narrative should be re-centered around the complementary value of structural signal.

### Minor
1. **"Outperforms" is overstated for the ESP benchmark**: On ESP (Table 1), ProteinVista achieves Acc=91.8%, ROC-AUC=0.951, MCC=0.78 vs ESM-2_650M's Acc=91.9%, ROC-AUC=0.955, MCC=0.79. ProteinVista is slightly worse on 3 of 4 metrics (better only on precision: 0.89 vs 0.86). The title's claim of universal outperformance does not hold for this benchmark.

2. **Extreme p-value (p < 10^{-304}) suggests numerical precision artifacts**: The one-sided Wilcoxon signed-rank test for IC50 regression (Section 3.2) reports p < 10^{-304}, which is below the numerical precision limits of standard floating-point arithmetic. While the difference is clearly significant, this should be reported as approximately p ≈ 0 with a note on the computation method.

3. **Rosetta-only absolute R² not reported**: The ablation (Section 4.2) reports only a 1.0% relative change from switching to Rosetta regression pretraining, but does not give the absolute R² of the Rosetta-only model. Since this is the key evidence for ProteinVista's independence from ESM-2 distillation, the absolute value should be stated in the main text.

4. **Extreme p-value (p < 10^{-304})**: Should be reported as p ≈ 0 with implementation details. (This is truly minor and does not affect the conclusion.)

### Trivial
- None.

## Nice-to-Haves
- The paper could discuss potential training/test overlap between the ~500K Swiss-Prot structures used for pre-training and the evaluation datasets, as this affects interpretability of the results.
- Reporting a single-model row for ProteinVista under the optimized pipeline (Table 1) would strengthen the analysis.
- Hyperparameter search details (range, number of trials, criterion) would aid reproducibility.

## Removed Points
- *"Rotation-invariant predictions claim is too strong"*: The paper says "aimed to achieve rotation-invariant predictions" (line 31), which is an aspiration, not an achieved claim. Removed as misinterpretation of modal language.
- *"Missing related works"*: Cannot verify without external sources. Removed.
- *"Missing appendix/proofs"*: The review system strips appendix content; these exist in the original submission. Removed.
- *"Formatting/style nitpicks"* and *"typos/grammar"*: These are parser artifacts, not author errors. Removed.
- *Strengths about "addressing an important problem" or "timely topic"*: Too generic to be substantive. Removed.
- *Criticism about FLOPs utilization being "implausible without explanation" while ignoring mixed-precision possibility*: The original framing was unnecessarily strong — mixed precision is a standard practice that could explain the throughput. Replaced with a more precise version that acknowledges the issue while recognizing the plausible explanation.

## Novel Insights
None beyond the paper's own contributions.

## Suggestions
1. **Resolve the compute timing puzzle**: Report FLOPs with precision specification (FP32 vs mixed precision), provide a brief roofline analysis, or clarify whether FLOP counts and wall-clock timings were measured under the same conditions (batch size, precision, data-loading overhead).
2. **Report the absolute R² of the Rosetta-only ablation** and explicitly state whether it still outperforms ESM-2_650M. This directly addresses the distillation concern.
3. **Add a row to Table 1** showing ProteinVista alone under the optimized pipeline to disentangle architecture effects from ensemble effects.
4. **Re-frame the title or abstract** to acknowledge that the advantage varies by task (strong on IC50 and TSP, tied on ESP, weaker on GO).
5. **Report extreme p-values** as "p ≈ 0" with a note on the computation method rather than p < 10^{-304}.
6. **Discuss potential training/test overlap** between the Swiss-Prot pre-training structures and evaluation datasets.

### Calibration Anchors
| Anchor | Path | Avg Score | Round | Comparison |
|--------|------|-----------|-------|------------|
| ProteinAdapter | jqx5XI4Yr3 | 3.40 | R1 | Weaker: less compelling method contribution, incremental gains over baselines |
| ProteiNexus | iBAWiEjogY | 3.67 | R1 | Weaker: novelty concerns, data leakage risks, missing baselines |
| E3former | QKywN4BbqA | 5.25 | R2 | Comparable: both have methodological contributions with framing/evidence issues; E3former's noise-robustness motivation questioned by reviewers |
| BindNet | AXbN2qMNiW | 5.67 | R2 | Comparable: similar level of evaluation rigor; BindNet has data leakage concerns while ProteinVista has compute/framing issues |
| EquiPocket | umUIYdLtvh | 5.50 | R2 | Slightly stronger: cleaner method but narrower scope (single task) |
| ProteinWorkshop | sTYuRVrdK3 | 6.25 | R1/R2 | Stronger: more polished execution, though a benchmark (not a method) paper |
| All-Atom Geom-GNNs | 4S2L519nIX | 6.50 | R2 | Stronger: more comprehensive analysis and cleaner narrative |
| SaProt | 6MRm3G4NiU | 7.33 | R2 | Much stronger: polished execution, clearer claims, broader evaluation |

**Round 1 bracket**: between 4.0 and 6.0 (above ProteiNexus/ProteinAdapter, below ProteinWorkshop/All-Atom Geom-GNNs)

**Round 2 narrowing**: Compared to E3former (5.25), BindNet (5.67), and EquiPocket (5.50), ProteinVista has a more ambitious contribution (reviving a class of architectures thought intractable) but also more unresolved issues (compute inconsistency, distillation framing). The paper is slightly below the EquiPocket/BindNet level due to the structural nature of its compute issue.

**Final score: 5.0** — The paper has a genuine contribution and the core experiments are well-designed, but the compute timing inconsistency, ensemble-dependent SOTA claims, and distilled-vs-compared framing prevent the paper from reaching ICLR acceptance threshold in its current form. These issues are addressable through revision.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>